Authors: Expert Workgroup of Experts consensus on preparation of low-concentration atropine sulfate for myopia progression control (2023), Shanghai Glasses Industry Association, Shanghai Medical Association Optometry Branch DOI: 10.3760/cma.j.cn115989-20230120-00023 Published 2023-03-10 Cite as Chin J Exp Ophthalmol, 2023, 41(3): 201-205. Abstract [Download PDF] […]
Tag: Disease progression
Repeated low-level red-light therapy: a novel method for myopia prevention and control
Authors: Zhu Zhuoting, He Mingguang DOI: 10.3760/cma.j.cn115989-20220127-00031 Published 2022-06-10 Cite asChin J Exp Ophthalmol, 2022, 40(6): 487-490. Abstract [View PDF] [Read Full Text] China has recently proposed a countrywide myopia control strategy for children and adolescents due to the rapidly increasing […]
Dynamic expression changes of Smad3 and type Ⅰ collagen in sclera of progressive myopia in guinea pigs
Authors: Jiang Bo, Wu Zhangyou, Zhu Zicheng, Hu Wei, Zhan Xin DOI: 10.3760/cma.j.issn.2095-0160.2017.06.003 Published 2017-06-10 Cite as Chin J Exp Ophthalmol, 2017,35(06): 491-497. Abstract [Download PDF] [Read Full Text] Background Sclera remodeling process in axial elongation is one of the main pathological mechanisms of axial myopia progression.Studies confirmed that transforming […]
Pedigree and clinical characteristics in a Chinese family with lattice corneal dystrophy
Authors: Peng Shiming, Zhao Jun, Zhu Tianhui, Huang Xiaosheng, Chen Wenjie, Mei Shaoyi, Wang Yan DOI: 10.3760/cma.j.issn.2095-0160.2017.08.007 Published 2017-08-10 Cite as Chin J Exp Ophthalmol, 2017,35(8): 704-708. Abstract [Download PDF] [Read Full Text] Background Lattice corneal dystrophy (LCD) is a progressive disease, whose clinical features are varied in different stages.It is rarely be […]